Leo Pharma initiates phase IIb studies of delgocitinib for atopic dermatitis and chronic hand eczema Dec. 3, 2018 No Comments
Positive phase II data presented, initiation of phase III pemphigus program announced for PRN-1008 Nov. 30, 2018 No Comments
First dosing in phase Ib study of EDP-1815 in psoriasis and atopic dermatitis Nov. 27, 2018 No Comments
Leo Pharma and PellePharm collaborate to advance innovative therapies for rare skin diseases Nov. 22, 2018 No Comments
Tremfya receives additional indication approval as first biologic agent for palmoplantar pustulosis Nov. 21, 2018 No Comments
Novan presents preliminary phase II results for SB-206 as treatment of molluscum contagiosum Nov. 15, 2018 No Comments
Promising interim results presented from phase IIa study of CTP-543 in patients with alopecia areata Nov. 13, 2018 No Comments
RSS